当前位置: X-MOL 学术Crit. Care Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Use of Airway Pressure Release Ventilation in Patients With Acute Respiratory Failure Due to Coronavirus Disease 2019: Results of a Single-Center Randomized Controlled Trial.
Critical Care Medicine ( IF 8.8 ) Pub Date : 2021-09-29 , DOI: 10.1097/ccm.0000000000005312
Miguel Á Ibarra-Estrada 1 , Yessica García-Salas 1, 2 , Eduardo Mireles-Cabodevila 3 , José A López-Pulgarín 1, 2 , Quetzalcóatl Chávez-Peña 1 , Roxana García-Salcido 1 , Julio C Mijangos-Méndez 1, 2 , Guadalupe Aguirre-Avalos 1, 2
Affiliation  

Airway pressure release ventilation is a ventilatory mode characterized by a mandatory inverse inspiratory:expiratory ratio with a very short expiratory phase, aimed to avoid derecruitment and allow spontaneous breathing. Recent basic and clinical evidence suggests that this mode could be associated with improved outcomes in patients with acute respiratory distress syndrome. The aim of this study was to compare the outcomes between airway pressure release ventilation and traditional ventilation targeting low tidal volume, in patients with severe coronavirus disease 2019.

中文翻译:

2019 年冠状病毒病引起的急性呼吸衰竭患者使用气道压力释放通气:单中心随机对照试验的结果。

气道压力释放通气是一种通气模式,其特征是具有非常短的呼气阶段的强制性反向吸气:呼气比,旨在避免肺复张并允许自主呼吸。最近的基础和临床证据表明,这种模式可能与改善急性呼吸窘迫综合征患者的预后有关。本研究的目的是比较气道压力释放通气与针对低潮气量的传统通气在 2019 年严重冠状病毒病患者中的结果。
更新日期:2021-09-29
down
wechat
bug